Monoclonal gammopathy of undetermined significance and anti-TNF-α treatment

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.36, Iss.5, 2007-01, pp. : 405-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal gammopathy of undetermined significance and anti-TNF-α treatment: comments on the article by Smale and Lawson

By Mielnik P

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 4, 2013-08 ,pp. : 335-336

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF-α therapy in membranous glomerulonephritis

By Santoro Domenico Postorino Adele Costantino Giuseppe Savica Vincenzo Bellinghieri Guido

Clinical Kidney Journal, Vol. 5, Iss. 5, 2012-10 ,pp. : 487-488

Oxford University Press

Access to resources Recommend Favorite

Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

By Kageyama Yasunori Takahashi Masaaki Torikai Eiji Suzuki Motohiro Ichikawa Tetsuya Nagafusa Tetsuyuki Koide Yukio Nagano Akira

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 505-509

Springer Publishing Company

Access to resources Recommend Favorite

The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients

By van Hoogmoed D Fransen J Repping-Wuts H Spee L Bleijenberg G van Riel PLCM

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 1, 2013-01 ,pp. : 15-19

Informa Healthcare

Access to resources Recommend Favorite

Psoriasis occurring during anti-TNF-α therapy: causal effect or unrelated?

By Stratigos Alexander J Sfikakis Petros P

Future Rheumatology, Vol. 1, Iss. 3, 2006-06 ,pp. : 281-284

Future Medicine

Access to resources Recommend Favorite